Search Results - "Raffin, Caroline"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Treg cell-based therapies: challenges and perspectives by Raffin, Caroline, Vo, Linda T., Bluestone, Jeffrey A.

    Published in Nature reviews. Immunology (01-03-2020)
    “…Cellular therapies using regulatory T (T reg ) cells are currently undergoing clinical trials for the treatment of autoimmune diseases, transplant rejection…”
    Get full text
    Journal Article
  2. 2
  3. 3

    MHC class II/ESO tetramer-based generation of in vitro primed anti-tumor T-helper lines for adoptive cell therapy of cancer by Poli, Caroline, Raffin, Caroline, Dojcinovic, Danijel, Luescher, Immanuel, Ayyoub, Maha, Valmori, Danila

    Published in Haematologica (Roma) (01-02-2013)
    “…Generation of tumor-antigen specific CD4(+) T-helper (T(H)) lines through in vitro priming is of interest for adoptive cell therapy of cancer, but the…”
    Get full text
    Journal Article
  4. 4

    Human RORγt⁺ TH17 cells preferentially differentiate from naive FOXP3⁺Treg in the presence of lineage-specific polarizing factors by Valmori, Danila, Raffin, Caroline, Raimbaud, Isabelle, Ayyoub, Maha

    “…RORγt⁺ TH17 cells are a proinflammatory CD4⁺ T-cell population associated with autoimmune tissue injury. In mice, priming of TH17 requires TGF-β, which alone…”
    Get full text
    Journal Article
  5. 5

    T reg cell-based therapies: challenges and perspectives by Raffin, Caroline, Vo, Linda T, Bluestone, Jeffrey A

    Published in Nature reviews. Immunology (01-03-2020)
    “…Cellular therapies using regulatory T (T ) cells are currently undergoing clinical trials for the treatment of autoimmune diseases, transplant rejection and…”
    Get full text
    Journal Article
  6. 6

    CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity by REDJIMI, Nassima, RAFFIN, Caroline, RAIMBAUD, Isabelle, PIGNON, Pascale, MATSUZAKI, Junko, ODUNSI, Kunle, VALMORI, Danila, AYYOUB, Maha

    Published in Cancer research (Chicago, Ill.) (01-09-2012)
    “…Antitumor type I T-cell responses involving IFN-γ production are critical to control cancer, but the efficacy of this response is limited by a variety of…”
    Get full text
    Journal Article
  7. 7

    T.sub.reg cell-based therapies: challenges and perspectives by Raffin, Caroline, Vo, Linda T, Bluestone, Jeffrey A

    Published in Nature reviews. Immunology (01-03-2020)
    “…Cellular therapies using regulatory T (T.sub.reg) cells are currently undergoing clinical trials for the treatment of autoimmune diseases, transplant rejection…”
    Get full text
    Journal Article
  8. 8

    Human memory Helios- FOXP3+ regulatory T cells (Tregs) encompass induced Tregs that express Aiolos and respond to IL-1β by downregulating their suppressor functions by Raffin, Caroline, Pignon, Pascale, Celse, Clotilde, Debien, Emilie, Valmori, Danila, Ayyoub, Maha

    Published in The Journal of immunology (1950) (01-11-2013)
    “…FOXP3(+) regulatory T cells (Tregs) are critical regulators of self-tolerance and immune homeostasis. In mice and humans, two subsets of FOXP3(+) Tregs have…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Ex vivo IL-1 receptor type I expression in human CD4+ T cells identifies an early intermediate in the differentiation of Th17 from FOXP3+ naive regulatory T cells by Raffin, Caroline, Raimbaud, Isabelle, Valmori, Danila, Ayyoub, Maha

    Published in The Journal of immunology (1950) (15-11-2011)
    “…IL-17-producing CD4(+) Th (Th17) cells are a unique subset of proinflammatory cells expressing the retinoic acid-related orphan receptor γt and associated with…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis by Raffin, Caroline, Zhou, Yu, Piccoli, Luca, Lanzavecchia, Antonio, Sadelain, Michel, Tareen, Semih U., Fontenot, Jason D., Bluestone, Jeffrey A.

    Published in The Journal of immunology (1950) (01-05-2018)
    “…Abstract Rheumatoid arthritis (RA) is one of the most common chronic autoimmune diseases that is characterized by an aberrant inflammation of the synovial…”
    Get full text
    Journal Article
  13. 13

    Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis by Raffin, Caroline, Muller, Yannick, Barragan, Jessica, Zhou, Yu, Piccoli, Luca, Lanzavecchia, Antonio, Tareen, Semih U, Fontenot, Jason D, Bluestone, Jeffrey A

    Published in The Journal of immunology (1950) (01-05-2019)
    “…Abstract Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by an aberrant inflammation of the synovial membrane that causes irreversible…”
    Get full text
    Journal Article
  14. 14

    Development of citrullinated-vimentin-specific CAR for targeting Tregs to treat autoimmune rheumatoid arthritis by Raffin, Caroline, Zhou, Yu, Piccoli, Luca, Lanzavecchia, Antonio, Sadelain, Michel, Bluestone, Jeffrey A

    Published in The Journal of immunology (1950) (01-05-2016)
    “…Abstract Rheumatoid arthritis (RA) is one of the most common chronic autoimmune diseases with a frequency of 0.5–1.0% in the adult population of developed…”
    Get full text
    Journal Article
  15. 15

    Natural CXCR3+ FOXP3+ Treg selectively accumulate in human ovarian carcinomas to control type I immunity (127.27) by Raffin, Caroline, Redjimi, Nassima, Odunsi, Kunle, Valmori, Danila, Ayyoub, Maha

    Published in The Journal of immunology (1950) (01-05-2012)
    “…Abstract Anti-tumor type I T cell responses are critical to control cancer but their efficacy is limited by immunoregulatory mechanisms, including the action…”
    Get full text
    Journal Article
  16. 16

    Human ROR[gamma]t+ T^sub H^17 cells preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific polarizing factors by Valmori, Danila, Raffin, Caroline, Raimbaud, Isabelle, Ayyoub, Maha

    “…ROR...t... T...17 cells are a proinflammatory CD4... T-cell population associated with autoimmune tissue injury. In mice, priming of T...17 requires TGF-β,…”
    Get full text
    Journal Article
  17. 17

    Human RORγt + T H 17 cells preferentially differentiate from naive FOXP3 + Treg in the presence of lineage-specific polarizing factors by Valmori, Danila, Raffin, Caroline, Raimbaud, Isabelle, Ayyoub, Maha

    “…RORγt + T H 17 cells are a proinflammatory CD4 + T-cell population associated with autoimmune tissue injury. In mice, priming of T H 17 requires TGF-β, which…”
    Get full text
    Journal Article